This year’s Heart Failure (HF) audit is based on 68,266 admissions to hospitals in England and Wales between April 2017 and March 2018.
Some of the findings from this year’s report are:
The prescription of key disease-modifying medicines for patients with heart failure and reduced left ventricular ejection fraction (HFrEF) has continued to increase
An increase in the number of patients seen by HF specialists (82%)
Post-discharge mortality rates at one year are substantially, and significantly, lower for those admitted to cardiology wards, those accessing cardiology follow-up, those offered cardiac rehabilitation and those discharged on the key disease-modifying medicines for HFrEF